N-((5-Chlorofuran-2-yl)methyl)-N-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide

ID: ALA4587341

PubChem CID: 151406722

Max Phase: Preclinical

Molecular Formula: C21H19ClN2O5

Molecular Weight: 414.85

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)c1ccc(N(Cc2ccc(Cl)o2)C(=O)c2ccc(O)cc2O)cc1

Standard InChI:  InChI=1S/C21H19ClN2O5/c1-23(2)20(27)13-3-5-14(6-4-13)24(12-16-8-10-19(22)29-16)21(28)17-9-7-15(25)11-18(17)26/h3-11,25-26H,12H2,1-2H3

Standard InChI Key:  OXQTXJIDMWRZLX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   20.8370   -6.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8358   -6.9278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5439   -7.3368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2535   -6.9273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2507   -6.1047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5421   -5.6994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1292   -5.6998    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.5437   -8.1540    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.9619   -7.3348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9632   -8.1520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.6689   -6.9251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3773   -7.3326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0844   -6.9229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6677   -6.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3749   -5.7038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3739   -4.8873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6650   -4.4790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9556   -4.8931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9601   -5.7082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6627   -3.6618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3692   -3.2512    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9538   -3.2553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0781   -3.6577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3668   -2.4340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8288   -7.2511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3747   -6.6430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9650   -5.9359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1660   -6.1071    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.2961   -5.1888    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  3  8  1  0
  4  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  1  0
 21 24  1  0
 13 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 13  1  0
 27 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4587341

    ---

Associated Targets(Human)

PDK2 Tchem Pyruvate dehydrogenase kinase isoform 2 (894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK1 Tchem Pyruvate dehydrogenase kinase isoform 1 (2021 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK3 Tchem Pyruvate dehydrogenase kinase isoform 3 (60 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 414.85Molecular Weight (Monoisotopic): 414.0982AlogP: 3.89#Rotatable Bonds: 5
Polar Surface Area: 94.22Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.82CX Basic pKa: CX LogP: 2.72CX LogD: 2.59
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.66Np Likeness Score: -1.19

References

1. Cho H, Shin I, Cho K, Yoon H, Yoon H, Yoo EK, Kim MJ, Park S, Lee IK, Kim ND, Sim T..  (2019)  Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors.,  62  (18): [PMID:31469962] [10.1021/acs.jmedchem.9b00565]
2. Morrell, J A JA and 5 more authors.  2003-12  AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2.  [PMID:14641019]
3. Moore, Jonathan D and 12 more authors.  2014-12-30  VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells.  [PMID:25404640]
4. Tso, Shih-Chia and 9 more authors.  2017-02-09  Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.  [PMID:28085286]

Source